Stanford engineers have genetically reprogrammed the cellular machinery of yeast to create microscopic factories that convert sugars and amino acids into plant-based drugs.
A School of Engineering senior associate dean discusses the myriad ways his colleagues throughout the school are discovering new — and often surprising — approaches to combating COVID-19.
A veteran educator takes aim at diversity in engineering and finds that the solution begins by bringing a breadth of life experiences to the classroom.